MYL5 as a Novel Prognostic Marker is Associated with Immune Infiltrating in Breast Cancer: A Preliminary Study

Figure 8

Connections of the expression level of MYL5 of BRCA patients with lymphocytes, immunomodulators, and chemokines in the TISIDB database. (a) The relationship between TILs and MYL5. (b–d) The relations between immunomodulators and MYL5. (e) and (f) Correlations of chemokines (or receptors) and MYL5.

(a)

(b)

(c)

(d)

(e)

(f)